Literature DB >> 23518334

[Management of brain metastases for lung cancer patients].

Fabrice Barlesi1, Natalia Khobta, Agnès Tallet, Anthony Goncalves, David Azria, Jean-Philippe Spano, Antoine F Carpentier, Jean Régis, Philippe Metellus.   

Abstract

Brain metastases from primary lung cancer represent 40% of all brain metastases. On the other hand, 10 to 80% of primary lung cancer patients will present with synchronous or metachronous brain metastases. Management of these patients is therefore a big challenge. The management will depend on the circumstances of diagnosis (symptomatic or not), the cancer history (synchronous or metachronous brain metastases), the histology and the number of lesions.

Entities:  

Keywords:  brain metastases; chemotherapy; lung cancer; neurosurgery; radiotherapy; stereotaxic radiosurgery; targeted therapy

Mesh:

Year:  2013        PMID: 23518334     DOI: 10.1684/bdc.2013.1721

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

Review 1.  Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer.

Authors:  Anna Patla; Tomasz Walasek; Jerzy Jakubowicz; Paweł Blecharz; Jerzy Władysław Mituś; Anna Mucha-Małecka; Marian Reinfuss
Journal:  Contemp Oncol (Pozn)       Date:  2016-12-20

Review 2.  Systemic treatment of non-small cell lung cancer brain metastases.

Authors:  Ida Cedrych; Maksymilian A Kruczała; Tomasz Walasek; Jerzy Jakubowicz; Paweł Blecharz; Marian Reinfuss
Journal:  Contemp Oncol (Pozn)       Date:  2016-12-20

3.  The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.

Authors:  Yanan Zhang; Zeyang Chen; Feng Jin; Dong Guo; Qingqing Chen; Zhengcao Liu; Shengjun Ji; Guanqi Gao
Journal:  Mediators Inflamm       Date:  2021-10-29       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.